India, July 15 -- Shares of Longevity Health Holdings, Inc. (XAGE) surged over 130% on Tuesday morning after the company announced merger deal with True Health Inc., a leading player in the fast growing plasma collection industry under the THPlasma brand, to combine the companies in an all-stock transaction.
XAGE is currently trading at $6.11, up $3.47 or 130.97%, on a large volume of 80 million shares, above average volume of 0.5 million, on the Nasdaq. The stock opened its trading at $6.46 after closing Monday at $2.64. The stock has traded between $2.20 and $48.60 in the past 52-week period.
Following the closing of the merger, the combined company is expected to continue to trade on Nasdaq under the symbol "XAGE."
googletag.cmd.push(...